Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2019, Issue -, Pages 1-10
Publisher
Hindawi Limited
Online
2019-11-12
DOI
10.1155/2019/7652014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Impact of prior antibiotic use on the efficacy of nivolumab for non‑small cell lung cancer
- (2019) Taiki Hakozaki et al. Oncology Letters
- The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant
- (2019) Delphine L. Lauté-Caly et al. Scientific Reports
- The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer
- (2019) Rossella Cianci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Commensal Microbiota Promote Lung Cancer Development via γδ T Cells
- (2019) Chengcheng Jin et al. CELL
- Gut microbiome and cancer immunotherapy
- (2019) Weina Li et al. CANCER LETTERS
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
- (2019) Tony S K Mok et al. LANCET
- Interplay between the lung microbiome and lung cancer
- (2018) Qixing Mao et al. CANCER LETTERS
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- EGFR–TKI-Associated Interstitial Pneumonitis in Nivolumab-Treated Patients With Non–Small Cell Lung Cancer
- (2018) Yasuo Oshima et al. JAMA Oncology
- Changes of microbiome profile during nivolumab treatment in NSCLC patients.
- (2018) Andrea Botticelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Host-microbe interactions mediating antitumorigenic effects of MRX0518, a gut microbiota-derived bacterial strain, in breast, renal and lung carcinoma.
- (2018) Alex Stevenson et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
- (2018) Luis Paz-Ares et al. NEW ENGLAND JOURNAL OF MEDICINE
- Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis
- (2018) Mingming Sun et al. Nature Communications
- Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
- (2018) Roberto Ferrara et al. JAMA Oncology
- Role of Immunotherapy for Oncogene-Driven Non-Small Cell Lung Cancer
- (2018) Yosuke Miura et al. Cancers
- Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects
- (2017) Hai-Xia Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
- (2017) Leora Horn et al. JOURNAL OF CLINICAL ONCOLOGY
- Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
- (2017) Sudarshan Paramsothy et al. LANCET
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
- (2017) Christian Milani et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- A pilot study using metagenomic sequencing of the sputum microbiome suggests potential bacterial biomarkers for lung cancer
- (2017) Simon J. S. Cameron et al. PLoS One
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Geography, Ethnicity or Subsistence-Specific Variations in Human Microbiome Composition and Diversity
- (2017) Vinod K. Gupta et al. Frontiers in Microbiology
- The gut–lung axis in tuberculosis
- (2017) Jorge Cervantes et al. Pathogens and Disease
- Desired Turbulence? Gut-Lung Axis, Immunity, and Lung Cancer
- (2017) Rea Bingula et al. Journal of Oncology
- The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease
- (2016) David N. O’Dwyer et al. JOURNAL OF IMMUNOLOGY
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
- (2016) Corey J Langer et al. LANCET ONCOLOGY
- Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions
- (2016) Sang Hoon Lee et al. LUNG CANCER
- The microbiome and innate immunity
- (2016) Christoph A. Thaiss et al. NATURE
- Emerging pathogenic links between microbiota and the gut–lung axis
- (2016) Kurtis F. Budden et al. NATURE REVIEWS MICROBIOLOGY
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting
- (2016) Luisa Carbognin et al. ONCOLOGIST
- The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer
- (2016) L. Horn et al. ONCOLOGIST
- Benefit-Risk Summary of Nivolumab for Patients With Metastatic Squamous Cell Lung Cancer After Platinum-Based Chemotherapy
- (2016) Dickran Kazandjian et al. JAMA Oncology
- Recurrent antibiotic exposure may promote cancer formation – Another step in understanding the role of the human microbiota?
- (2015) Ben Boursi et al. EUROPEAN JOURNAL OF CANCER
- Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
- (2015) Paul Moayyedi et al. GASTROENTEROLOGY
- Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis
- (2015) Noortje G. Rossen et al. GASTROENTEROLOGY
- The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia
- (2015) Tim J Schuijt et al. GUT
- Potential role of the intestinal microbiota in programming health and disease: Figure 1
- (2015) Olivier Goulet NUTRITION REVIEWS
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- The microbiome at the pulmonary alveolar niche and its role in Mycobacterium tuberculosis infection
- (2015) Alexander J. Adami et al. TUBERCULOSIS
- Regulation of lung immunity and host defense by the intestinal microbiota
- (2015) Derrick R. Samuelson et al. Frontiers in Microbiology
- Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers
- (2015) Luisa Carbognin et al. PLoS One
- Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer
- (2015) Jiabei He et al. Scientific Reports
- Role of the Microbiota in Immunity and Inflammation
- (2014) Yasmine Belkaid et al. CELL
- The role of the microbiome in exacerbations of chronic lung diseases
- (2014) Robert P Dickson et al. LANCET
- Lung microbiota promotes tolerance to allergens in neonates via PD-L1
- (2014) Eva S Gollwitzer et al. NATURE MEDICINE
- Microbial Succession in the Gut: Directional Trends of Taxonomic and Functional Change in a Birth Cohort of Spanish Infants
- (2014) Yvonne Vallès et al. PLoS Genetics
- The murine lung microbiome in relation to the intestinal and vaginal bacterial communities
- (2013) Kenneth Barfod et al. BMC MICROBIOLOGY
- Commensal bacteria at the interface of host metabolism and the immune system
- (2013) Jonathan R Brestoff et al. NATURE IMMUNOLOGY
- Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
- (2013) Els van Nood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human intestinal microbiota composition is associated with local and systemic inflammation in obesity
- (2013) Froukje J. Verdam et al. Obesity
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
- (2013) N. Iida et al. SCIENCE
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
- (2013) S. Viaud et al. SCIENCE
- Origins of tumor-associated macrophages and neutrophils
- (2012) V. Cortez-Retamozo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function
- (2012) T. Olszak et al. SCIENCE
- Transient TLR Activation Restores Inflammatory Response and Ability To Control Pulmonary Bacterial Infection in Germfree Mice
- (2011) C. T. Fagundes et al. JOURNAL OF IMMUNOLOGY
- Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD
- (2011) John R. Erb-Downward et al. PLoS One
- Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis
- (2010) Y. K. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
- (2010) K. Atarashi et al. SCIENCE
- IL-23 and Autoimmunity: New Insights into the Pathogenesis of Inflammatory Bowel Disease
- (2008) Clara Abraham et al. Annual Review of Medicine
- The Biology of Intestinal Immunoglobulin A Responses
- (2008) Andrea Cerutti et al. IMMUNITY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now